Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4776
GrafTech
EAF
$246M
| $9.14K | ﹤0.01% |
940
-27,020
| -97% | -$239K |
2018 Q2
28 quarters
|
|
4777
AllianzIM U.S. Equity 6 Month Buffer10 Apr/Oct ETF
SIXO
$120M
| $9.01K | ﹤0.01% |
272
-4,113
| -94% | -$131K |
2025 Q1
1 quarter
|
|
|
ABPWW
4778
DELISTED
Abpro Holdings Warrant
ABPWW
| $8.78K | ﹤0.01% |
250,000
| – | – |
2022 Q2
12 quarters
|
|
4779
Lloyds Banking Group
LYG
$79.1B
| $8.71K | ﹤0.01% |
2,050
| – | – |
2015 Q2
40 quarters
|
|
|
AWP
4780
abrdn Global Premier Properties Fund
AWP
$314M
| $8.37K | ﹤0.01% |
704
| – | – |
2015 Q4
38 quarters
|
|
|
OTF
4781
Blue Owl Technology Finance Corp
OTF
$4.39B
| $8.28K | ﹤0.01% |
+543
| New | +$8.55K |
2025 Q2
0 quarters
|
|
4782
Innovator Premium Income 15 Buffer ETF January
LJAN
$12.3M
| $8.04K | ﹤0.01% |
+327
| New | +$7.96K |
2025 Q2
0 quarters
|
|
|
ZNOV
4783
Innovator Equity Defined Protection ETF - 1 Yr November
ZNOV
$106M
| $8.01K | ﹤0.01% |
+309
| New | +$7.81K |
2025 Q2
0 quarters
|
|
|
INZY
4784
DELISTED
Inozyme Pharma
INZY
| $8K | ﹤0.01% |
2,001
-60,302
| -97% | -$149K |
2022 Q1
13 quarters
|
|
4785
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.59B
| $7.89K | ﹤0.01% |
+5
| New | +$17K |
2025 Q2
0 quarters
|
|
|
ADUR
4786
Aduro Clean Technologies
ADUR
$438M
| $7.55K | ﹤0.01% |
843
| – | – |
2024 Q4
2 quarters
|
|
4787
LiveOne
LVO
$36.1M
| $7.36K | ﹤0.01% |
975
-6,848
| -88% | -$50.9K |
2024 Q2
4 quarters
|
|
4788
DLH Holdings
DLHC
$58.7M
| $7.26K | ﹤0.01% |
1,244
-7,628
| -86% | -$34.5K |
2023 Q3
7 quarters
|
|
4789
iShares MSCI Qatar ETF
QAT
$56.2M
| $7.26K | ﹤0.01% |
390
| – | – |
2019 Q4
22 quarters
|
|
|
HELP
4790
Helus Pharma Inc. Common Stock
HELP
$855M
| $7.23K | ﹤0.01% |
+862
| New | +$6.27K |
2025 Q2
0 quarters
|
|
|
DCOY
4791
Decoy Therapeutics
DCOY
$1.16M
| $7.19K | ﹤0.01% |
+45
| New | +$6.33K |
2025 Q2
0 quarters
|
|
4792
Kamada
KMDA
$480M
| $7.18K | ﹤0.01% |
926
| – | – |
2023 Q3
7 quarters
|
|
4793
Biomea Fusion
BMEA
$92.1M
| $7.01K | ﹤0.01% |
3,893
-29,795
| -88% | -$57.4K |
2022 Q1
13 quarters
|
|
4794
Prelude Therapeutics
PRLD
$293M
| $6.96K | ﹤0.01% |
8,602
-14,543
| -63% | -$12.6K |
2022 Q1
13 quarters
|
|
|
PARAA
4795
DELISTED
Paramount Global Class A
PARAA
| $6.91K | ﹤0.01% |
301
+210
| +231% | +$4.75K |
2022 Q1
13 quarters
|
|
|
CTNM
4796
Contineum Therapeutics
CTNM
$494M
| $6.88K | ﹤0.01% |
1,732
-9,351
| -84% | -$40.6K |
2024 Q2
4 quarters
|
|
4797
iShares International Developed Real Estate ETF
IFGL
$75.6M
| $6.82K | ﹤0.01% |
300
| – | – |
2017 Q4
30 quarters
|
|
4798
Century Therapeutics
IPSC
$277M
| $6.82K | ﹤0.01% |
12,197
-35,012
| -74% | -$18.8K |
2022 Q1
13 quarters
|
|
|
SIMAU
4799
SIM Acquisition Corp I Unit
SIMAU
| $6.69K | ﹤0.01% |
654
| – | – |
2024 Q4
2 quarters
|
|
4800
iShares International Dividend Growth ETF
IGRO
$1.25B
| $6.63K | ﹤0.01% |
84
| – | – |
2017 Q4
30 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.